Arthur M. Blank Hospital, Inc
Locations
Transplant Summary
Overview
Arthur M. Blank Hospital has a 26 Bed BMT Unit. The entire unit is a HEPA-filtered, positive-pressure environment.This center has been performing allogeneic transplants since 1985 and has been an NMDP transplant center since April 1999.
Attending physicians
Adult - Alan Bidgoli, Shanmuganathan Chandrakasan, Taylor Fitch, Ann Haight, Ed Horowitz, Kathy Leung, Wayne Liang, Suhag Parikh, Muna Qayed, Michelle Schoettler, Elizabeth Stenger, Kirsten Willams
Pediatric - Alan Bidgoli, Shanmuganathan Chandrakasan, Taylor Fitch, Ann Haight, Ed Horowitz, Kathy Leung, Wayne Liang, Suhag Parikh, Muna Qayed, Michelle Schoettler, Elizabeth Stenger, Kirsten WillamsTransplants performed
Marrow/PBSC and single cordCord blood transplants
Pediatric onlyOther programs and services
GVHD clinic; Ex-sickle cell clinic; access to Ronald McDonald Housing.Patient survival information for this center
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 133 patients.The actual 1-year survival of these patients is 81.1%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 81.7% and 92.6%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total pediatric transplants
158
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow36PBSC11Cord blood3Total50Unrelated donorMarrow33PBSC11Cord blood3Total47Total allogeneicMarrow69PBSC22Cord blood6Total97AutologousMarrowBoth marrow & PBSC 61PBSC—Cord blood—Total61Total combinedMarrowBoth marrow & PBSC 152PBSC—Cord blood6Total158All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-184719-44445-64065+0Total51Unrelated 0-184019-44745-64065+0Total47Autologous 0-186019-44145-64065+0Total61Total 0-1814719-441245-64065+0Total159Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Survivor Program, Aflac Cancer and Blood Disorders Center., Children's Healthcare of Atlanta - Egleston
5461 Meridian Mark Road Atlanta, GA 30342 Phone:404-785-1717 For more information about this program: https://www.choa.org/medical-services/cancer-and-blood-disorders/cancer/cancer-survivor-program (Opens in a new tab)Overview
At the Aflac Cancer Center, we believe survivors of childhood and adolescent cancer who have been off treatment for approximately two years should have long-term follow-up care in a specialized survivor program. Blood and marrow transplant survivors treated for non-cancer conditions should also participate. Through our survivor program, we offer: - Multidisciplinary care focused on the survivor's needs - Review of the patient's medical history - Complete evaluations, including a physical exam, blood work and any other tests needed - A personalized plan of care based on national guidelines produced by the Children's Oncology Group (COG) - Education about the risks of medical problems associated with the specific cancer treatments the survivor received - Help with school, job or insurance issues - Support for any physical or emotional changes or difficulties - Opportunities to enroll in research studies that focus on survivors and the late effects of treatment.
Staff
Program Director:Karen Effinger, MD, MSProgram Coordinator:Kathryn English, RN, BSNMedical Specialties in Program
Endocrinology, hematology, oncology, psychiatry/psychology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Children- Allogeneic and Autologous transplant recipients
- 1 year after transplant.
- Patients who were transplanted as a child at this center with no upper age limit
- Does accept patients who were transplanted at another hospital
- Will admit pediatric patients who transferred into the program if they are under age 21